These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1506661)

  • 1. The effect of alcohol-induced hepatomegaly on portal hypertension in cirrhotic rats.
    Dagenais M; Giroux L; Belgiorno J; Huet PM
    J Hepatol; 1992 May; 15(1-2):88-93. PubMed ID: 1506661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic effects of blood volume restitution following a hemorrhage in rats with portal hypertension due to cirrhosis of the liver: influence of the extent of portal-systemic shunting.
    Kravetz D; Bosch J; Arderiu M; Pilar Pizcueta M; Rodés J
    Hepatology; 1989 Jun; 9(6):808-14. PubMed ID: 2714733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of spleen on inducing portal hypertension and liver cirrhosis in rats].
    Chen S
    Zhonghua Yi Xue Za Zhi; 1992 Jun; 72(6):338-40, 381-2. PubMed ID: 1332811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of simvastatin, pentoxifylline and spironolactone on hepatic fibrosis and portal hypertension in rats with bile duct ligation.
    Oberti F; Pilette C; Rifflet H; Maïga MY; Moreau A; Gallois Y; Girault A; le Bouil A; Le Jeune JJ; Saumet JL; Feldmann G; Calès P
    J Hepatol; 1997 Jun; 26(6):1363-71. PubMed ID: 9210625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased blood flow through the portal system in cirrhotic rats.
    Vorobioff J; Bredfeldt JE; Groszmann RJ
    Gastroenterology; 1984 Nov; 87(5):1120-6. PubMed ID: 6479534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
    Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
    Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of portacaval surgical anastomosis on systemic and splanchnic hemodynamics in portal hypertensive, cirrhotic rats.
    Romeo JM; López-Farré A; Martín-Paredero V; López-Novoa JM
    Can J Physiol Pharmacol; 1988 Dec; 66(12):1493-8. PubMed ID: 3228783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenobarbitone-induced enlargement of the liver in the rat: its relationship to carbon tetrachloride-induced cirrhosis.
    Chatamra K; Proctor E
    Br J Exp Pathol; 1981 Jun; 62(3):283-8. PubMed ID: 7248170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rat liver microcirculation in alcohol-induced hepatomegaly.
    Mastaï R; Huet PM; Brault A; Belgiorno J
    Hepatology; 1989 Dec; 10(6):941-5. PubMed ID: 2583688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.
    Di Pascoli M; Diví M; Rodríguez-Vilarrupla A; Rosado E; Gracia-Sancho J; Vilaseca M; Bosch J; García-Pagán JC
    J Hepatol; 2013 May; 58(5):904-10. PubMed ID: 23262250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in liver fibrosis, functionality and hemodynamics in CCI4-cirrhotic rats after injection of the Liver Growth Factor.
    Díaz-Gil JJ; Muñoz J; Albillos A; Rúa C; Machín C; García-Cañero R; Cereceda RM; Guijarro MC; Trilla C; Escartín P
    J Hepatol; 1999 Jun; 30(6):1065-72. PubMed ID: 10406185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of intrahepatic pressure with collagen in the Disse space and hepatomegaly in humans and in the rat.
    Orrego H; Blendis LM; Crossley IR; Medline A; Macdonald A; Ritchie S; Israel Y
    Gastroenterology; 1981 Mar; 80(3):546-56. PubMed ID: 7450445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of platelet activating factor and its antagonist on portal hypertension associated with liver cirrhosis: an experiment with rats].
    Wang CP; Han J; Ma XM; Dong K; Xiang Y; Su SH; Feng YY; Yang YP
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3337-41. PubMed ID: 16409839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodynamic characterization in experimental liver cirrhosis induced by thioacetamide administration.
    Hori N; Okanoue T; Sawa Y; Mori T; Kashima K
    Dig Dis Sci; 1993 Dec; 38(12):2195-202. PubMed ID: 8261820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites.
    López-Talavera JC; Levitzki A; Martínez M; Gazit A; Esteban R; Guardia J
    J Clin Invest; 1997 Aug; 100(3):664-70. PubMed ID: 9239414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extrahepatic angiogenesis hinders recovery of portal hypertension and collaterals in rats with cirrhosis resolution.
    Hsu SJ; Tsai MH; Chang CC; Hsieh YH; Huang HC; Lee FY; Chuang CL; Hou MC; Lee SD
    Clin Sci (Lond); 2018 Mar; 132(6):669-683. PubMed ID: 29449343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of liver regeneration on the portal pressure and vascular pattern in normal and cirrhotic rats.
    Banerjee AK; Aikat BK
    J Pathol Bacteriol; 1968 Oct; 96(2):327-35. PubMed ID: 5698706
    [No Abstract]   [Full Text] [Related]  

  • 18. Transplantation of endothelial progenitor cells ameliorates vascular dysfunction and portal hypertension in carbon tetrachloride-induced rat liver cirrhotic model.
    Sakamoto M; Nakamura T; Torimura T; Iwamoto H; Masuda H; Koga H; Abe M; Hashimoto O; Ueno T; Sata M
    J Gastroenterol Hepatol; 2013 Jan; 28(1):168-78. PubMed ID: 22849788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenobarbital in comparison with carbon tetrachloride and phenobarbital-induced cirrhosis in rat liver regeneration.
    Hashimoto M; Kothary PC; Raper SE
    J Surg Res; 1999 Feb; 81(2):164-9. PubMed ID: 9927535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension.
    Schaffner D; Lazaro A; Deibert P; Hasselblatt P; Stoll P; Fauth L; Baumstark MW; Merfort I; Schmitt-Graeff A; Kreisel W
    World J Gastroenterol; 2018 Oct; 24(38):4356-4368. PubMed ID: 30344420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.